Abstract
gens. All patients received calcium carbonate as a phosphate Statistical analysis binder in a mean dosis of 4.5±3.5 g daily. Aluminiumcontaining phosphate binders were used periodically in 35 All values are expressed as mean±SD. Chi square test patients, when plasma phosphate concentration exceeded was used for evaluation frequences. Non-parametric 2 mmol/l.
Kruskal-Wallis and Mann-Whitney tests were applied to compare inter-group differences. A P<0.05 was considered as statistically significant.
Laboratory measurements
Serum calcium and inorganic phosphate concentrations were estimated on the day before dialysis using standard technics.
Alkaline phosphatase bone fraction activity was assessed as Results the thermolabile fraction of total alkaline phosphatase activity using the King-Armstrong method. Serum intact 1,84 The distribution of BsmI VDR genotypes is shown in PTH was measured with the use of two-site immunoradio- [7] , and osteocalcin deviation from Hardy-Weinberg equilibrium was [8] by radioimmunoassay method. 1,25(OH ) 2 D3 was evaluated by HPLC method described by Scharla et al. [9] .
observed for the haplotypes. There were no significant differences between individuals with three genotype concerning age, gender distribution, duration of preBone mineral density ceding haemodialysis treatment, concentration of calcium in dialysis fluid, phosphate binder policy and
Whole body, lumbar spine (L 2-4 ), and femoral neck bone mineral density (BMD) was measured by dual-energy X-ray body mass index ( Table 1) . While there was no signiabsorptiometry technic (DEXA) using a DPX scanner ficant differences of serum calcium, phosphates and (Lunar Radiation Corp.). The in-house maximum error of osteocalcin there was a trend for the alkaline phosphatrepetitive measurements is ±3%. BMD was expressed in ase bone fraction (significant only initially) and iPTH g/cm2. The measurement of each patient was given as Z-score (significant only after 18 months) to be higher in BB of the reference value corrected for age and gender (age/sex individuals, while 25(OH )D3, 1,25(OH ) 2 D3 levels matched ). Measurements were performed twice at an interval were even significantly lower ( Table 2) . individuals with BB genotype ( Figure 1 ).
K digestion was followed by phenol-chloroform extraction and ethanol precipitation: 100 ng of DNA was used as a
The separate analysis of women and men showed template for PCR amplification. PCR was performed in 40 ml more rapid rate of bone mineral loss in females (whole volume containing 50 mM KCl, 10 mM Tris pH 7, 1.5 mM body mineral loss −4.12 vs −2.55% respectively). MgCl 
2
, 200 mM dNTP and 2 pM of primers [2] for 30 cycles Regardless of gender faster loss was observed in with 30 s denaturation at 94°C, 45 s annealing at 60°C and BB individuals then bb, however differences were 60 s extension at 72°C. PCR product was digested after not significant ( low number of subjects) i.e. BB precipitation with Mva12691 (MBI Fermentas) at 37°C for −6.82±5.2%; Bb −3.86±4.3%; bb −2.52±3.2% in 3 h and separated on 1.5% agarose gel. Alleles were visualized women and BB −3.66±2.9%; Bb −2.17±2.6%; bb by staining the gel with ethidium bromide. The lack of restriction site defines the B allele. −1.94±2.3% in men. 
